A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis
AACE Clinical Case Reports · 2025-01 · 11 (1) · 66-69
DOI: 10.1016/j.aace.2024.11.002 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Clinical Case Reports, 2025-01. Verfasst von Kevin S Wei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Keck School of Medicine at USC, Los Angeles, California. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background/Objective: Thyrotoxic periodic paralysis (TPP) is a rare condition causing weakness of the lower extremities associated with significant hypokalemia. Likewise, agranulocytosis due to methimazole use is a rare occurrence. We present the first documented case of concomitant TPP and agranulocytosis from methimazole use. Case Report: A 48-year-old woman presented with sore throat, fevers, odynophagia, and sudden-onset bilateral leg weakness. Methimazole had been started 10 weeks prior for a new diagnosis of Graves' disease. On admission, the patient was febrile, tachycardic, thyrotoxic, and neutropenic. She also experienced near-paralysis of the lower extremities. She was diagnosed with TPP and treated with beta blockade. She was admitted to the intensive care unit and started on broad-spectrum antibiotics, lithium, and propranolol for treatment of septic shock and hyperthyroidism, respectively. Given persistent hypokalemia despite 2 days of therapy, she was also diagnosed with refeeding syndrome.
Discussion
TPP is a rare entity, though it should be considered on the differential for any thyrotoxic patient presenting with sudden weakness. If the associated hypokalemia does not begin to normalize within 48 h of beta blockade, other etiologies should be investigated. Lastly, alternative treatments such as lithium may be used to control hyperthyroidism in patients with methimazole-induced agranulocytosis.
Conclusion
While methimazole-induced agranulocytosis and thyrotoxic periodic paralysis are independently rare diagnoses, the combination of the 2 is exceedingly rare, and our case represents the first documented case in the literature reflecting a patient suffering from both syndromes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Keck School of Medicine at USC, Los Angeles, California.
- Division of Endocrinology, Diabetes and Metabolism, UCLA Health, Los Angeles, California.
Zitieren
APA
Wei, K. S., Lim, A. N., & Cannon, S. M. (2025). A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis. AACE Clinical Case Reports, 11(1), 66-69. https://doi.org/10.1016/j.aace.2024.11.002
Vancouver
Wei KS, Lim AN, Cannon SM. A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis. AACE Clinical Case Reports. 2025;11(1):66-69. doi:10.1016/j.aace.2024.11.002
BibTeX
@article{Wei2025,
author = {Wei, Kevin S and Lim, Alexandra N and Cannon, Sophie M},
title = {A Rare Case of Thyrotoxic Periodic Paralysis in a Patient With Concomitant Methimazole-Induced Agranulocytosis},
journal = {AACE Clinical Case Reports},
year = {2025},
volume = {11},
number = {1},
pages = {66--69},
doi = {10.1016/j.aace.2024.11.002}
}
EUVIMED